Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Recrystallization for API Purification – V 2.0

Posted on By

API Manufacturing: SOP for Recrystallization for API Purification – V 2.0

Standard Operating Procedure for Recrystallization for API Purification in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/028/2025
Supersedes SOP/API/028/2022
Page No. Page 1 of 11
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define a standardized procedure for the recrystallization of APIs or intermediates to enhance product purity and meet defined quality specifications while complying with GMP regulations.

2. Scope

This SOP is applicable to all recrystallization operations performed in the API manufacturing facility using single-solvent or mixed-solvent systems for purification purposes.

3. Responsibilities

  • Production Operator: Perform recrystallization as per BMR.
  • Process Chemist: Determine solvent suitability and solubility profiles.
  • QA Officer: Verify process parameters, sampling, and documentation.
  • Engineering Team: Ensure reactor, condenser, and utilities are functional.
See also  API Manufacturing: SOP for Handling of Quarantined Materials - V 2.0

4. Accountability

The Production Head is accountable for execution, and the QA Head is accountable for review and compliance verification.

5. Procedure

5.1 Preparation and Pre-Checks

  1. Review the BMR for:
    • Solvent type and volume
    • Temperature range
    • Cooling rate
  2. Ensure equipment (reactor, stirrer, condenser, vacuum line) is clean and ready.
  3. Verify calibration of temperature probes and solvent tanks.

5.2 Dissolution

  1. Charge the crude API to the reactor.
  2. Add specified solvent gradually with agitation.
  3. Heat the mixture to the defined temperature (e.g., 60–90°C) until a clear solution is obtained.
  4. Maintain temperature for 15–30 minutes to ensure complete dissolution.

5.3 Filtration (If Required)

  1. If any insoluble material remains, filter the hot solution through a pre-heated filter assembly or sparkler filter.
  2. Collect filtrate in a clean dry vessel.

5.4 Crystallization

  1. Initiate cooling of the clear solution under controlled conditions:
    • Rapid cooling for nucleation
    • Slow cooling for crystal growth
  2. Maintain agitation throughout the cooling phase.
  3. Optional: Seed crystals may be added to induce crystallization as per BMR.
  4. Cool to 0–5°C or specified temperature and hold for minimum 2 hours.
See also  API Manufacturing: SOP for Process Yield Calculation and Documentation - V 2.0

5.5 Filtration and Drying of Crystals

  1. Filter the crystal slurry using Nutsche or centrifuge.
  2. Wash crystals with chilled solvent to remove impurities.
  3. Collect and label wet cake; send for drying.
  4. Record weight, time, and observations in “Recrystallization Logbook” (Annexure-1).

5.6 Post-Recrystallization Cleaning

  1. Flush reactor with solvent or water depending on product compatibility.
  2. Clean filters and centrifuge as per respective SOPs.
  3. Document cleaning in “Equipment Cleaning Record.”

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Recrystallization Logbook (Annexure-1)
  2. Equipment Cleaning Record (Annexure-2)
  3. Solvent Usage Record (Annexure-3)

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • USP <761> – Solubility Guidelines
  • 21 CFR Part 211 – Current Good Manufacturing Practice

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Recrystallization Logbook

Batch No. Solvent Heating Temp Cooling Temp Crystallization Start Time End Time Yield (%)
API-202504 IPA 75°C 5°C 11:00 14:00 92.4%

Annexure-2: Equipment Cleaning Record

Equipment ID Cleaned On Cleaned By Verified By Remarks
R-102 13/04/2025 Clean and Dry

Annexure-3: Solvent Usage Record

Date Batch No. Solvent Quantity Used (L) Recovered (L) Operator
13/04/2025 API-202504 IPA 80 68

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2022 1.0 Initial SOP Release New Process Inclusion QA Head
13/04/2025 2.0 Included Seeding and Mixed-Solvent Guidance Process Optimization QA Head
See also  API Manufacturing: SOP for Raw Material Sampling Procedure - V 2.0
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Medical History Documentation in Healthy Volunteers – V 2.0
Next Post: Tablets: SOP for Blister Packing of Immediate Release Tablets – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version